Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 8 | 2014 | 496 | 1.470 |
Why?
|
| Chloride Channels | 4 | 2013 | 63 | 1.210 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 141 | 1.050 |
Why?
|
| Dynamins | 1 | 2022 | 40 | 0.820 |
Why?
|
| Epileptic Syndromes | 1 | 2022 | 30 | 0.810 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2011 | 168 | 0.670 |
Why?
|
| Brain Diseases | 1 | 2022 | 296 | 0.670 |
Why?
|
| Craniosynostoses | 1 | 2021 | 131 | 0.630 |
Why?
|
| Chlorides | 3 | 2012 | 104 | 0.590 |
Why?
|
| Sleep | 2 | 2024 | 344 | 0.570 |
Why?
|
| Intellectual Disability | 2 | 2023 | 1041 | 0.570 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 268 | 0.560 |
Why?
|
| Brain Neoplasms | 4 | 2014 | 1236 | 0.530 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 2 | 2013 | 14 | 0.530 |
Why?
|
| Repressor Proteins | 1 | 2021 | 810 | 0.520 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 698 | 0.520 |
Why?
|
| Hemimegalencephaly | 1 | 2015 | 1 | 0.510 |
Why?
|
| Hemispherectomy | 1 | 2015 | 27 | 0.490 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 604 | 0.490 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2018 | 306 | 0.490 |
Why?
|
| Rett Syndrome | 2 | 2018 | 289 | 0.470 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 121 | 0.450 |
Why?
|
| Bradykinin | 1 | 2013 | 57 | 0.420 |
Why?
|
| Ion Channels | 2 | 2011 | 188 | 0.420 |
Why?
|
| Chemotaxis | 1 | 2013 | 55 | 0.420 |
Why?
|
| TRPC Cation Channels | 1 | 2012 | 22 | 0.420 |
Why?
|
| Cell Movement | 2 | 2014 | 831 | 0.380 |
Why?
|
| Mitosis | 1 | 2011 | 238 | 0.360 |
Why?
|
| Transcription Factors | 1 | 2021 | 2585 | 0.360 |
Why?
|
| Brain | 2 | 2019 | 2962 | 0.340 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 175 | 0.340 |
Why?
|
| Mutation | 3 | 2022 | 5765 | 0.320 |
Why?
|
| Verbal Behavior | 1 | 2009 | 52 | 0.310 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 256 | 0.310 |
Why?
|
| Calcium | 2 | 2012 | 1096 | 0.310 |
Why?
|
| Exons | 2 | 2022 | 794 | 0.300 |
Why?
|
| Reading | 1 | 2009 | 80 | 0.300 |
Why?
|
| Feedback | 1 | 2009 | 162 | 0.290 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2018 | 34 | 0.280 |
Why?
|
| Epilepsy, Absence | 1 | 2023 | 31 | 0.220 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 2524 | 0.220 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 64 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 759 | 0.210 |
Why?
|
| Causality | 1 | 2022 | 83 | 0.210 |
Why?
|
| Cell Line, Tumor | 5 | 2013 | 3293 | 0.200 |
Why?
|
| Phenotype | 3 | 2023 | 4221 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1872 | 0.200 |
Why?
|
| Neuroglia | 1 | 2024 | 193 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 2 | 2013 | 277 | 0.190 |
Why?
|
| Humans | 17 | 2023 | 123075 | 0.180 |
Why?
|
| Heterozygote | 1 | 2022 | 672 | 0.180 |
Why?
|
| Muscle Hypotonia | 1 | 2021 | 185 | 0.170 |
Why?
|
| Infant | 4 | 2023 | 12355 | 0.160 |
Why?
|
| Young Adult | 4 | 2023 | 8838 | 0.160 |
Why?
|
| Capillary Permeability | 1 | 2019 | 78 | 0.160 |
Why?
|
| CREB-Binding Protein | 1 | 2019 | 63 | 0.160 |
Why?
|
| Endocytosis | 1 | 2019 | 124 | 0.160 |
Why?
|
| Drosophila Proteins | 1 | 2024 | 707 | 0.150 |
Why?
|
| Microcephaly | 1 | 2021 | 328 | 0.150 |
Why?
|
| Neoplasms | 1 | 2011 | 2758 | 0.130 |
Why?
|
| Animals | 8 | 2024 | 33791 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2023 | 13881 | 0.130 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 105 | 0.120 |
Why?
|
| Astrocytes | 1 | 2018 | 251 | 0.120 |
Why?
|
| Adolescent | 4 | 2023 | 19097 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2019 | 845 | 0.120 |
Why?
|
| Central Nervous System | 1 | 2016 | 254 | 0.120 |
Why?
|
| Cell Size | 2 | 2011 | 81 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 59 | 0.120 |
Why?
|
| Symporters | 1 | 2014 | 66 | 0.110 |
Why?
|
| Male | 8 | 2023 | 60082 | 0.110 |
Why?
|
| Status Epilepticus | 1 | 2015 | 139 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 289 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 174 | 0.110 |
Why?
|
| Electric Conductivity | 1 | 2012 | 89 | 0.100 |
Why?
|
| Adult | 4 | 2023 | 29014 | 0.100 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2012 | 23 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 467 | 0.100 |
Why?
|
| Osmotic Pressure | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cell Shape | 1 | 2011 | 61 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2011 | 178 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 350 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 1100 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3074 | 0.090 |
Why?
|
| Cell Division | 1 | 2011 | 780 | 0.090 |
Why?
|
| Child | 3 | 2023 | 24226 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2011 | 460 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 198 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2011 | 241 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2010 | 269 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1688 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2011 | 614 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3544 | 0.070 |
Why?
|
| Epilepsy | 1 | 2014 | 857 | 0.070 |
Why?
|
| Peptides | 1 | 2010 | 794 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2010 | 1608 | 0.060 |
Why?
|
| Female | 4 | 2021 | 65532 | 0.060 |
Why?
|
| Apoptosis | 1 | 2012 | 1782 | 0.060 |
Why?
|
| Genotype | 2 | 2023 | 2533 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2848 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1261 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2307 | 0.060 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 2 | 1 | 2023 | 1 | 0.060 |
Why?
|
| Lipids | 1 | 2024 | 514 | 0.040 |
Why?
|
| Neurons | 2 | 2024 | 1935 | 0.040 |
Why?
|
| Homeostasis | 1 | 2024 | 683 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12123 | 0.040 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2019 | 16 | 0.040 |
Why?
|
| Drosophila | 1 | 2024 | 766 | 0.040 |
Why?
|
| Facies | 1 | 2019 | 155 | 0.040 |
Why?
|
| Time Factors | 1 | 2009 | 6222 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 872 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 573 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1115 | 0.030 |
Why?
|
| Interneurons | 1 | 2014 | 138 | 0.030 |
Why?
|
| Clotrimazole | 1 | 2012 | 4 | 0.030 |
Why?
|
| Staurosporine | 1 | 2012 | 21 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 23 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 17538 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2012 | 84 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2395 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 348 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 123 | 0.020 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2011 | 6 | 0.020 |
Why?
|
| Bumetanide | 1 | 2011 | 7 | 0.020 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2011 | 7 | 0.020 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2011 | 35 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 279 | 0.020 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2011 | 31 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 571 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 664 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 555 | 0.020 |
Why?
|